Warburg Pincus Will Pay $227.3M For ReSearch Pharma
Private equity firm Warburg Pincus will acquire ReSearch Pharmaceutical Services Inc. in a deal valued at roughly $227.3 million, Reuters said. The firm has offered $6.10 per shares for the clinical research firm.





